Stress and glucocorticoid stress hormones inhibit neurogenesis, whereas antidepressants increase neurogenesis and block stress-induced decrease in neurogenesis. Our previous studies have shown that leptin, an adipocyte-derived hormone with antidepressant-like properties, promotes baseline neurogenesis in the adult hippocampus. This study aimed to determine whether leptin is able to restore suppression of neurogenesis in a rat chronic unpredictable stress (CUS) model of depression. Chronic treatment with leptin reversed the CUS-induced reduction of hippocampal neurogenesis and depression-like behaviors. Leptin treatment elicited a delayed long-lasting antidepressant-like effect in the forced swim behavioral despair test, and this effect was blocked by ablation of neurogenesis with X-irradiation. The functional isoform of the leptin receptor, LepRb, and the glucocorticoid receptor (GR) were colocalized in hippocampal neural stem/progenitor cells in vivo and in vitro. Leptin treatment reversed the GR agonist dexamethasone (DEX)-induced reduction of proliferation of cultured neural stem/progenitor cells from adult hippocampus. Further mechanistic analysis revealed that leptin and DEX converged on glycogen synthase kinase-3b (GSK-3b) and b-catenin. While DEX decreased Ser9 phosphorylation and increased Tyr216 phosphorylation of GSK-3b, leptin increased Ser9 phosphorylation and attenuated the effects of DEX at both Ser9 and Tyr216 phosphorylation sites of GSK-3b. Moreover, leptin increased total level and nuclear translocation of b-catenin, a primary substrate of GSK-3b and a key regulator in controlling hippocampal neural progenitor cell proliferation, and reversed the inhibitory effects of DEX on b-catenin. Taken together, our results suggest that adult neurogenesis is involved in the delayed long-lasting antidepressant-like behavioral effects of leptin, and leptin treatment counteracts chronic stress and glucocorticoid-induced suppression of hippocampal neurogenesis via activating the GSK-3b/b-catenin signaling pathway.
Introduction
New neurons are continuously generated throughout adulthood from a pool of neural stem/progenitor cells in the subgranular zone of the dentate gyrus of the hippocampus. In a tightly regulated process, these cells divide and give rise to granule cells that extend axons along the mossy fiber pathway and are capable of integrating into functional hippocampal circuitry. [1] [2] [3] These events are modulated both positively or negatively by neurotransmitters, 4-10 hormones, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] neurotrophic factors, 10, 19, [21] [22] [23] [24] [25] [26] [27] pharmacological agents and environmental factors. [28] [29] [30] Among the regulatory factors of hippocampal neurogenesis, stress, a participating and precipitating factor of depression, potently inhibits neurogenesis in adult animals. 16, [31] [32] [33] [34] [35] For example, chronic stress paradigms, including chronic unpredictable stress (CUS), chronic mild stress and chronic social defeat stress that can induce depression-like behaviors, have been reported to decrease proliferation of neural progenitor cells in the dentate gyrus. [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] Also, a decrease in hippocampal neurogenesis has been demonstrated in other rodent models of stress such as repeated restraint stress, 48, 49 predator odor [50] [51] [52] [53] and footshock stress. [54] [55] [56] [57] These findings suggest that a reduction of hippocampal neurogenesis is a common consequence of various types of stress. The mechanisms underlying stress-induced decrease of neurogenesis is most likely to be mediated by activation of the hypothalamic-pituitary-adrenal axis and subsequent elevation of glucocorticoid stress hormones during stress. Indeed, elevation of glucocorticoid stress hormones or administration of exogenous glucocorticoids decreases hippocampal neurogenesis, 12, 13, 47, [58] [59] [60] [61] [62] [63] [64] and depletion of glucocorticoids by adrenalectomy attenuates stress-reduced neurogenesis. 50 Chronic treatment with a variety of antidepressants, including selective serotonin reuptake inhibitors, norepinephrine reuptake inhibitors and monoamine oxidase inhibitors, increases basal adult hippocampal neurogenesis and reverses the inhibitory effects of stress and glucocorticoids on neurogenesis. 8, 26, 33, 47, 54, 61, 62, [65] [66] [67] Further studies indicate that some behavioral effects of antidepressants are neurogenesis-dependent under chronic stress or glucocorticoid treatment conditions. 47, 62 Our earlier studies demonstrate that leptin, an adipocyte-derived hormone with antidepressant-like efficacy, 68 promotes adult hippocampal neurogenesis under basal conditions. 69 This finding provides evidence for adipostatic control of adult neurogenesis. However, it remains unknown whether leptin can reverse or oppose the reduction of neurogenesis induced by stress. Leptin is known to enter the brain by a saturable transport system, 70 where it exerts its biological functions via interacting with leptin receptors. Among six isoforms of the leptin receptor (LepRa-f) that have been identified, 71, 72 LepRb is the functional isoform as it possesses all the intracellular motifs required for signal transduction. We have previously shown that LepRb is expressed in hippocampal neural stem/progenitor cells of adult hippocampus. 69 The glucocorticoid receptor (GR) has also been reported to be present in hippocampal neural stem/progenitor cells, 73, 74 suggesting a possible interaction between leptin signaling and glucocorticoid signaling in the regulation of neurogenesis. In this study, we examined the effects of leptin on hippocampal neurogenesis and behaviors in a CUS model of depression and the involvement of hippocampal neurogenesis in the antidepressant-like behavioral effects of leptin. Further in vitro mechanistic studies investigated the effects of leptin on glucocorticoidinduced inhibition of neurogenesis and the underlying molecular mechanisms involving the glycogen synthase kinase-3b (GSK-3b)/b-catenin signaling pathway.
Materials and methods

Animals
Male Sprague-Dawley rats, weighing 250-300 g, were purchased from Charles River Laboratories (Wilmington, MA, USA). Rats were housed in groups of three. All animals were maintained on a 12-h light/dark cycle (lights on at 0700 h) with ad libitum access to food and water. Animals were habituated to housing conditions for 7-10 days before the beginning of experimental procedures. All procedures were carried out in accordance with the National Institutes of Health Guide.
Drug treatment
Recombinant rat leptin (R&D Systems, Minneapolis, MN, USA) was dissolved in sterile saline at a concentration of 1 mg/ml and intraperitoneally injected into animals daily at a dose of 1 mg/kg body weight.
CUS paradigm
The CUS procedure was carried out in rats as described in our earlier report. 68 This paradigm was designed to maximize unpredictability and mildness of the stress intensity. It consisted of a variety of stressors applied randomly and at varying times of the day for 21 days (see Supplementary Table 1 for detailed protocol). Rats were first divided into two groups, that is, handled control (n = 7) and CUS (n = 13) groups. All stressors were applied to animals outside of their housing area in a separate procedure room. After the animals were stressed, they were kept in the procedure room for 1-2 h to allow the stress odor to disappear. All control and stressed animals were housed in groups of 2-3, except when they were subjected to isolation, high-density housing or behavioral testing. Control rats (n = 7) were handled daily in the housing room. At 21 days after the beginning of the CUS procedure, CUS rats were further divided into two groups. One group received intraperitoneal injection of leptin (1 mg/kg) (n = 5) and the other received vehicle (saline) injection (n = 8), given 30 min before the application of stress daily. This dose of leptin was chosen based on its effectiveness in inducing antidepressant-like effects. 68, 75 During the 14 days of leptin or vehicle treatment, CUS rats were continuously exposed to stressors as shown in Supplementary Table 1 . Handled control rats received only vehicle treatment. All animals were subjected to three behavioral tests to confirm induction of depression-like behaviors in CUS rats as described below.
Behavioral testing
The open-field test was performed to examine exploratory activity and fear response to novelty. The apparatus was made of black acrylic plastic. The light intensity in the four corners of the arena was adjusted to ensure the arena had uniform illumination. At the beginning of the test, the animal was placed in the center of the arena and allowed to freely explore for 5 min. Animals were video-tracked using the Noldus EthoVision 3.0 system (Noldus Information Technology, Leesburg, VA, USA). The apparatus was cleaned after each testing session to prevent any odors deposited by the rats from influencing the following rat. Total distance traveled, movement velocity and freezing time were measured.
For the sucrose preference test, in order to habituate the animals to the two bottle situation and to avoid neophobia during testing, two bottles, one with water and one with 1% sucrose solution, were placed in each rat cage 2 days before the CUS procedure and 21 days after CUS exposure began. A 1% sucrose solution was chosen to assess anhedonia based on previous studies reported by us as well as other groups. 68, [76] [77] [78] [79] Rats were tested for sucrose preference on days 30 and 35. On testing days, animals were individually housed and provided with a free choice between plain water and 1% sucrose right before the dark cycle. The bottle position was balanced within the group and rotated between tests to avoid side preference. The amount of water and sucrose consumed over the dark cycle was measured by weight. Sucrose preference was expressed as a ratio of sucrose intake volume over water intake volume.
The forced swim test was performed as described previously. 68 Briefly, animals were placed in a cylindrical tank (60 cm height, 30 cm diameter) filled with tap water (25 1C) to a depth of 45 cm for 5 min. The behaviors in the forced swim test were recorded by two video cameras with one positioned on top of the swimming tank and another positioned on the side. The recorded behavior of the rats was scored using a time sampling technique to rate the predominant behavior over a 5 s interval as described by Lucki. 80 Immobility was defined as floating or no active movements made other than what is necessary to keep their nose above water. Swimming was defined as active motions throughout the swim tank and crossing into another quadrant. Climbing was evaluated as upward-directed movements of the forepaws against the wall.
X-ray irradiation X-ray irradiation was performed using a modified protocol from previously reported studies. [81] [82] [83] Rats were anesthetized and subjected to cranial irradiation using a Faxitron X-ray system (58 kV, 3.0 mA). A lead shield was designed to protect the entire body of the rat from X-ray exposure while leaving a small ovalshaped area (1.5 Â 2 cm 2 ) over the hippocampus open to X-ray exposure. On two consecutive days, 10 Gy (X-irradiation) each day was delivered over 14.7 min to anesthetized animals placed in a plastic restrainer. This paradigm and dose for irradiated rats has been well established and used in previous studies to reduce hippocampal neurogenesis without adverse side effects. 81, 82, 84, 85 Sham controls were taken to the X-ray facility and anesthetized, but not subjected to irradiation. After a 4-week recovery period, leptin (1 mg/kg) or saline was administered to the rats intraperitoneally once per day for 14 consecutive days.
In vivo adult hippocampal neurogenesis BrdU injection. Bromodeoxyuridine (BrdU) was used to label proliferating cells and track the fate of newly proliferated cells. The same rats used for behavior testing were injected with BrdU 2 h after the last drug administration or 24 h after the last stressor was applied to CUS rats. The length of the S phase was estimated to be approximately 8 h. 86 Thus, three injections of BrdU were given intraperitoneally (50 mg/kg) to the animals, at 8-h intervals over 24 h. The rate of cell proliferation was determined by killing the animals 2 h after the third BrdU injection. To track the fate of BrdU-labeled cells, animals were killed 28 days after the last BrdU injection.
Tissue preparation. Animals were anesthetized with an intramuscular injection of an anesthetic cocktail (43 mg/kg ketamine, 9 mg/kg xylazine and 1.4 mg/kg acepromazine in saline) and perfused through the ascending aorta using 0.1 M sodium phosphate-buffered saline (PBS), followed by 4% paraformaldehyde in PBS. The brain was removed and fixed overnight in 4% paraformaldehyde, and then transferred to 30% sucrose in PBS. Brains were cut into 40 mm coronal sections on a cryostat and stored in cryoprotectant (30% sucrose, 30% ethylene glycol, 1% polyvinyl pyrrolidone, 0.05 M sodium phosphate buffer) until processing for immunohistochemistry.
Immunohistochemistry. Immunohistochemistry for BrdU was performed as described previously. 69 Briefly, free floating sections were washed in 0.1 M. PBS followed by incubation in a solution of 1 Â saline-sodium citrate buffer (SSC) and 50% formamide for 2 h at 60 1C. Next, the sections were treated with 2 N HCl for 30 min at 37 1C, followed by incubation in 0.1 M boric acid buffer. In all, 1% hydrogen peroxide in PBS was used to quench the endogenous peroxidase of the sections. The tissue was then incubated in immunoblocking buffer (3% goat serum, 1% bovine serum albumin (BSA), 0.3% Triton X-100 in PBS) for 1 h, followed by mouse anti-BrdU primary antibody (1:200; Roche, Indianapolis, IN, USA) in blocking solution overnight at 4 1C. After rinsing in PBS buffer, the sections were then incubated with a biotinylated goat anti-mouse antibody in blocking solution (1:400) for 1 h at room temperature. The tissue was washed in PBS, followed by subsequent incubation with avidin-biotin complex (1:100; Vector Laboratories, Burlingame, CA, USA) for 1 h. BrdU immunoreactivity was revealed using 3 0 -diaminobenzidine (Vector Laboratories, Burlingame, CA, USA).
To determine if BrdU-labeled cells expressed neuronal or glial phenotypes, brain sections were processed for BrdU, neuronal nuclei (NeuN) or antiglial fibrillary acidic protein (GFAP) fluorescent double labeling. The tissue was first treated for BrdU immunohistochemistry as described above with some modifications. To detect BrdU, the tissue was incubated with rat-anti-BrdU antibody (1:200; Accurate Chemical, Westburg, NY, USA) and mouse anti-NeuN (1:400; Chemicon International, Temecula, CA, USA) or rabbit anti-GFAP (1:1000; Chemicon International). After overnight incubation in primary antibody, the sections were washed in PBS and incubated for 4 h with fluorescent secondary antibodies: Alexa Fluor 488 goat anti-rat imuunoglobulin G (IgG) to reveal immunoreactivity of BrdU and Alexa Fluor 546 goat anti-mouse IgG or Alexa Fluor 546 goat antirabbit IgG to reveal immunoreactivity of NeuN or GFAP, respectively (1:400 for all three antibodies; Molecular Probes, Eugene, OR, USA). Then, the sections were rinsed in PBS and mounted onto poly-lysine-coated glass slides and coverslipped with fluorescence mounting medium.
Cell counting. Every sixth section throughout the entire rostral-caudal extent of the hippocampus was used to determine the number of BrdU-labeled cells within the dentate gyrus. Counting was accomplished using Â 400 magnification on an Olympus BX51 microscope.
Cells were counted bilaterally throughout the dentate gyrus. The number of BrdUlabeled cells was multiplied by 6 to obtain the total number of cells per dentate gyrus. For cell differentiation experiments, a total of 70 BrdUpositive cells were counted for BrdU/NeuN and BrdU/GFAP and visualized on an Olympus FV-1000 confocal microscope. Colocalization with NeuN or GFAP was confirmed by examining multiple optical planes for each cell on the z axis. The percentage of BrdU-positive cells double-labeled for NeuN or GFAP was determined.
Adult hippocampal neural stem/progenitor cell culture. Adult hippocampal stem cells isolated from adult Fisher rats (Millipore, Billerica, MA, USA) were grown and maintained on poly-L-ornithine-and laminin-coated plates as a monolayer in neural expansion media (DMEM:F12 nutrient mix plus B-27 supplement and 20 ng/ml b-fibroblast growth factor). The cultured adult hippocampal neural stem cells were tested for the expression of neural stem cell marker nestin and showed no expression of markers for differentiated cells.
Triple-labeling method combining in situ hybridization and immunohistochemistry in vivo and in vitro. For in vivo detection of LepRb mRNA and GR and nestin proteins in the dentate gyrus, in situ hybridization was used in combination with immunohistochemistry. Rats were transcardially perfused with 2% paraformaldehyde, post-fixed for 2 h and subsequently immersed in 30% sucrose in PBS. Brains were sectioned at 20 mm and thaw mounted onto poly-lysine-coated glass slides. To detect LepRb mRNA, with in situ hybridization, brain sections were fixed with 4% paraformaldehyde in PBS and then washed in 2 Â SSC buffer (pH 7.2). The tissue was then acetylated using 0.1 M triethanolamine (pH 8.0) with 0.25% acetic anhydride for 10 min, and subsequently dehydrated through a graded series of alcohol (50-100%). An antisense cRNA probe directed against the C-terminal sequence of LepRb, was labeled with biotin-16-UTP using the standard transcription system as described in our previous studies. 87 Hybridization was performed by incubating the tissue sections in 70 ml of hybridization buffer containing 5 ml of labeled probe at 55 1C overnight in humidified chambers. The tissue sections were then rinsed in 2 Â SSC and incubated in RNase A buffer (200 mg/ml) for 1 h at 37 1C, followed by a series of washes of increasing stringency (2 Â , 1 Â and 0.5 Â SSC for 5 min each). Finally, the tissue slides were washed with 0.1 Â SSC at 70 1C for 1 h. The Tyramide Signal Amplification Plus Biotin Kit (Perkin-Elmer, Waltham, MA, USA) was used to detect the biotinlabeled LepRb probe. First, the slides were washed in 0.05 M PBS (pH 7.4), followed by 2% H 2 O 2 for 30 min and then incubated in the in situ blocking solution for 1 h. Next, the slides were incubated in streptavidin conjugated to horseradish peroxidase (1:1000; Roche) in blocking solution, followed by incubation in the biotinyl tyramide in amplification diluent provided with the Tyramide Signal Amplification Plus Biotin Kit. Following three rinses in 0.05 M PBS and incubation in 2% H 2 O 2 for 30 min, immunohistochemical staining for GR and nestin was performed before completion of LepRb detection. The tissue slides were rinsed and then incubated in immunoblocking buffer containing 3% goat serum, 1% BSA and 0.3% Triton X-100 in PBS, followed by incubation with antibodies for GR (1:500; Santa Cruz, Santa Cruz, CA, USA) and nestin (1:100; Chemicon International) overnight. The next day, after the tissue sections were rinsed, Alexa Fluor 546 goat anti-rabbit IgG was used to reveal immunoreactivity of GR, and Alexa Fluor 647 goat anti-mouse IgG was used to detect nestin. Then, the tissue sections were incubated in the in situ blocking solution and streptavidin-conjugated to alkaline phosphatase (1:100), and subsequently the Enzyme-Labeled Fluorescence-97 Endogenous Phosphatase Detection kit (Molecular Probes) was used to visualize LepRb signals.
For detection of triple-labeling of LepRb mRNA and the GR and nestin proteins in vitro, adult hippocampal neural stem/progenitor cells were seeded onto poly-L-ornithineand laminin-coated glass coverslips and grown overnight. The cells were processed for in situ hybridization as described for in vivo studies above. To detect biotin-labeled LepRb probe, the Tyramide Signal Amplification Plus Cyanine 2 System (Perkin Elmer) was used. Coverslips were washed in 0.1 M phosphate buffer (pH 7.4), followed by incubation with 2% H 2 O 2 for 20 min. Next, blocking solution was applied for 1 h at room temperature and streptavidin-conjugated to horseradish peroxidase was added to detect biotin-labeled LepRb probes. LepRb signals were subsequently detected using the Tyramide Signal Amplification Plus Cyanine 2 System. Then, coverslips were incubated in 2% H 2 O 2 for 20 min, followed by immunoblocking buffer (1% BSA, 3% goat serum, 0.3% Triton X-100) for 1 h and then primary antibodies diluted in blocking solution overnight (mouse anti-nestin, 1:1000; rabbit anti-GR, 1:500). Next, coverslips were washed in PBS and subsequently incubated in secondary antibodies diluted in blocking solution (biotinylated goat anti-mouse antibody, 1:400; Alexa Fluor 546 goat anti-rabbit antibody, 1:400; Molecular Probes) for 4 h. Then, streptavidin conjugated to Alexa Fluor 647 (1:1000; Molecular Probes) was added to visualize nestin immunoreactivity.
Immunocytochemistry for BrdU and b-catenin. Adult hippocampal neural stem/progenitor cells were seeded on poly-ornithine-and laminin-coated 8-well chamber slides. A total of four wells were treated for each condition as follows: vehicle, 1 nM leptin, 10 mM dexamethasone (DEX), 10 mM DEX with 0.1 nM, 1 nM or 3 nM leptin, and grown for 48 h. BrdU (10 mM) was added to the media for the last 4 h, after which the cells were fixed with 4% paraformaldehyde in PBS. After washing in PBS, the cells were incubated in 2 N HCl for 30 min at 37 1C, followed by 0.1 M boric acid buffer. Immunoblocking solution was added to each well of the chamber slide for 1 h. For BrdU detection, the cells were incubated in mouse anti-BrdU (Roche) primary antibody diluted in blocking solution overnight at 4 1C. The slides were washed in PBS, followed by incubation in secondary antibody, Alexa Fluor 488 goat anti-mouse IgG and coverslipped using fluorescence mounting media. Cell proliferation was determined by counting BrdU-labeled cells in each well. Five random fields were chosen under the Â 20 objective, and the total number of BrdU-labeled cells was counted.
To detect nuclear translocation of b-catenin, adult hippocampal neural stem/progenitor cells were seeded at a density of 2 Â 10 4 cells per ml onto polyornithine-and laminin-coated glass coverslips in 12-well plates. The cells were treated with vehicle, 10 mM DEX, 10 mM DEX with 1 nM leptin or 1 nM leptin, and grown for 48 h, after which the cells were fixed with 4% paraformaldehyde in PBS. The cells were then rinsed in PBS, followed by treatment with immunoblocking buffer (3% goat serum, 1% BSA, 0.3% Triton X-100 in PBS), and subsequently incubated with rabbit anti-b-catenin antibody (1:500; Abcam, Cambridge, MA, USA) overnight at 4 1C. The cells were washed in PBS, followed by incubation in Alexa Fluor 488 goat anti-rabbit IgG and mounted using fluorescent mounting media.
Western blot. Cells were plated on polyornithineand laminin-coated 6-well polystyrene plates and grown in neural expansion media for 24 h. The cells were treated with vehicle, 10 mM DEX, 10 mM DEX with 1 nM leptin or 1 nM leptin. The cells were harvested after 20 min, and total protein was extracted using cell lysis buffer (50 mM Hepes, pH 7.6, 1% Triton X-100, 150 mM NaCl, 20 mM sodium pyrophosphate, 20 mM b-glycerophosphate, 10 mM NaF) containing a mixture of phosphatase inhibitors (leupeptin, aprotinin, sodium orthovanadate, phenylmethylsulfonyl fluoride, Ser/Thr phosphatase inhibitor mixture, Tyr phosphatase inhibitor mixture).
The total protein concentration was assessed using the Bradford assay and equal amounts were run on a sodium dodecyl sulfate-polyacrylamide gel. The proteins were then transferred to a nitrocellulose membrane and blocked in a solution of 1% BSA and 0.05% Tween-20 in 1 Â Tris-buffered saline. The membranes were incubated in blocking solution containing primary antibody (anti-GSK-3b, 1:1000 (Cell Signaling, Danvers, MA, USA); anti-phosphorylated GSK-3b on Ser9, 1:1000 (Cell Signaling); anti-GSK-3b phosphorylated on Tyr216, 1:1000 (Abcam); anti-b-catenin, 1:5000 (Abcam)) overnight at 4 1C. After washing, the membrane was incubated in anti-rabbit secondary antibody conjugated to horseradish peroxidase (1:5000) in blocking solution for 1 h. Next, the membrane was washed in Tris-buffered saline and the electrogenerated chemiluminescence reaction solutions were added (solution 1: 0.1 M Tris-HCl, luminol, p-coumaric acid; solution 2: 0.1 M Tris-HCl, hydrogen peroxide) for 1 min. The membrane was exposed to X-ray film (Phenix Research Products, Candler, NC, USA) for visualization.
Nuclear protein extraction. Nuclear lysates were isolated using the nuclear extraction kit (Chemicon International). Cells were grown to approximately 50% confluency on 10 cm poly-ornithine-and laminin-coated plates and treated for 48 h with vehicle, 10 mM DEX, 1 nM leptin or a combination of 10 mM DEX and 1 nM leptin. Cells were harvested and nuclear extract was isolated. The cell pellet was resuspended in cytoplasmic lysis buffer containing 0.5 mM dithiothreitol and protease inhibitors and disrupted using a 27 G syringe needle. Once the cytoplasmic portion of the cells was purified, nuclear extraction followed using nuclear extraction buffer containing 0.5 mM dithiothreitol and protease inhibitors. Total b-catenin present in the nuclear extract was evaluated using western blot with an antibody specific for b-catenin (anti-b-catenin, 1:5000; Abcam) and normalized to b-actin.
Statistical analysis. Results were expressed as mean ± s.e.m. Statistical analyses were performed with one-way analysis of variance (ANOVA) with repeated measures on body weight and one-way ANOVA without repeated measures on behavioral tests, cell proliferation and differentiation, and two-way ANOVA on the X-irradiation study, phosphorylation of GSK-3b and b-catenin levels. Student-Newman-Keuls or Tukey/Kramer (for unequal n) post hoc comparisons followed ANOVAs. Two-tailed t-test was used for the rest of the experiments.
Results
Suppression of cell proliferation in adult hippocampus and induction of behavioral depression by CUS
First, we determined whether adult hippocampal neurogenesis can be suppressed in a rat CUS model of depression. Rats subjected to a CUS procedure daily for 21 days (detailed in Supplementary Table 1) were assessed in three behavioral tests. In the openfield test, CUS rats displayed decreased exploration (P < 0.01), moving velocity (P < 0.01) and increased freezing (P < 0.01). In the sucrose preference test, the CUS rats showed anhedonia-like behavior (P < 0.05), as indicated by reduced preference for 1% sucrose solution. In the forced swim test, CUS rats displayed despair behavior as indicated by increased time of immobility (P < 0.01) (Supplementary Figure S1A -C). To examine whether adult hippocampal neurogenesis is impaired by chronic stress, cell proliferation in the dentate gyrus was evaluated by detecting BrdU-labeled cells at 2 h after BrdU injection. CUS exposure reduced the number of BrdU-labeled cells in the dentate gyrus (P < 0.05) (Supplementary Figure S1D) . These results support the validity of the rat CUS procedure as an animal model of depression and as an effective model to examine the effect of leptin on chronic stress-induced suppression of adult hippocampal neurogenesis.
Reversal of CUS-induced suppression of adult hippocampal neurogenesis and depression-like behaviors by administration of leptin
Using the CUS model established above, the effects of leptin on the stress-induced suppression of adult hippocampal neurogenesis and behavioral deficits were examined. Rats were first exposed to the CUS procedure for 21 days, followed by 14 days of leptin treatment (1 mg/kg) or vehicle during which CUS exposure continued ( Supplementary Table 1 ) (Figure 1a ). For behavioral tests, ANOVA indicated that there were significant differences among three treatments in their effects on open-field behaviors: Exploratory activity (F (2, 17) velocity (P < 0.0001), and an increase in freezing (P < 0.0001) compared with the vehicle-treated control rats, but leptin treatment had no significant effect on any open-field measure (P > 0.5) ( Figure 1b ). ANOVA showed a main effect of treatment on sucrose preference (F (2,13) = 7.19, P < 0.01). Post hoc tests indicated that vehicle-treated CUS rats had a significantly lower preference for sucrose solution than the vehicle-treated control rats (P < 0.05), and leptin treatment reversed the CUS-induced decrease in sucrose preference (P = 0.01) (Figure 1c ). In the forced swim test, ANOVA revealed main effects of treatment on immobility (F (2,26) = 8.78, P = 0.001), swimming (F (2,26) = 10.74, P < 0.0005) and climbing (F (2,26) = 4.01, P < 0.05). Post hoc tests demonstrated that leptin treatment significantly decreased immobility time (P < 0.001) and increased swimming activity in CUS rats (P < 0.0001) (Figure 1d ). Reversal of CUS-induced 'behavioral despair' and 'anhedonia' by chronic leptin treatment confirmed the antidepressant potential of leptin. In addition, the effects of CUS and leptin on body weight were monitored (Figure 1e ). ANOVA with repeated measures indicated that the CUS exposure significantly decreased body weight gain before leptin or vehicle treatment (F (2,46) = 8.789, P < 0.0001). After rats received leptin or vehicle administration, ANOVA showed a main effect of treatment on body weight gain (F (2,170) = 7.90, P < 0.005). Post hoc tests revealed a significant decrease in body weight gain in vehicle-treated CUS rats compared with vehicle-treated control rats. Leptin treatment in CUS rats further decreased body weight gain compared with vehicle treatment (P < 0.01). The effect of leptin on adult hippocampal neurogenesis in CUS rats was assessed by analyzing BrdU labeling (Figure 2a ). Cell proliferation was assessed at 2 h after BrdU labeling. ANOVA revealed a main effect of treatment on the total number of BrdUpositive cells (F (2,17) = 5.56, P = 0.01). CUS exposure significantly decreased the total number of BrdUpositive cells compared with control ( Figure 2b ; P < 0.05), and this effect of CUS was significantly reversed by chronic leptin treatment (P < 0.01). The survival of newly proliferated cells in the dentate gyrus was examined 28 days after BrdU administration ( Figure 2c ). ANOVA indicated a significant effect of treatment on the total number of BrdU-positive cells that survived (F (2,17) = 17.57, P < 0.0001). The vehicle-treated CUS group exhibited a significantly lower number of survived BrdU-positive cells than in the vehicle-treated control group (P < 0.01), and this effect of CUS was partially reversed by leptin treatment (P = 0.01) (Figure 2c, left panel) . The majority of survived BrdU-positive cells exhibited a neuronal phenotype, that is, colocalizing with NeuN; however, there was no significant effect of treatment on the percentage of BrdU-labeled cells that were double-labeled for NeuN (F (2,16) = 1.89, P = 0.184) (Figures 2c (right panel) and d) . A low percentage of survived BrdU-positive cells were colocalized with GFAP (Figures 2c (right panel) and d) . CUS exposure decreased the percentage of BrdU-positive cells differentiated into the glia (P < 0.001), and this was reversed by treatment with leptin. Taken together, these data support that leptin is capable of reversing the CUS-induced suppression of neurogenesis in the adult hippocampus.
Involvement of hippocampal neurogenesis in mediating the long-lasting antidepressant-like behavioral effects of leptin
To test the involvement of leptin-induced hippocampal neurogenesis in mediating the antidepressant-like effects of leptin, animals were first exposed to a sham procedure or X-irradiation (10 Gy per day for 2 consecutive days) to induce ablation of hippocampal neurogenesis. 81, 82 At 28 days after exposure to the sham procedure or X-irradiation, one set of animals was injected with BrdU to examine the effectiveness of X-irradiation in blocking neurogenesis. As reported in previous studies, 81, 82 we found that X-irradiation at this dose greatly reduced BrdU-labeled cells in the dentate gyrus (Figure 3a) , which confirmed ablation of hippocampal neurogenesis.
To determine whether new neurons stimulated by leptin contribute to its antidepressant-like efficacy, 28 days after X-irradiation, animals were treated for 14 days with leptin to upregulate neruogenesis, followed by a 14-day delay to permit functional integration of new-born neurons during leptin treatment. ANOVA revealed a significant effect of irradiation (F (1, 22) = 5.34, P < 0.05), but not treatment on immobility (F (1, 22) = 3.42, P = 0.08). There was a marginally significant effect of irradiation Â treatment interaction on immobility (F (1,22) = 3.81, P = 0.06). Post hoc analysis indicated that leptin treatment significantly reduced immobility time in sham animals (P < 0.05), whereas X-irradiation abolished the effect of leptin on (Figure 3c ). Climbing time was not affected by irradiation or treatment (F (1, 22) = 0.06, P = 0.81 for irradiation; F (1, 22) = 1.09, P = 0.31 for treatment; F (1, 22) = 0.03, P = 0.82 for irradiation Â treatment). To determine the immediate effects on immobility and swimming in the forced swim test following leptin treatment, some animals exposed to the sham procedure were tested at the end of 14 days of leptin treatment. We found that leptin treatment significantly decreased immobility time and increased swimming time without a significant effect on climbing time (Figure 3c ). These effects of leptin are unlikely to be related to leptin-induced neurogenesis as newborn neurons take about 4 weeks to achieve mature connectivity. 88 These results, together with our previous findings, 68 indicate that leptin produces both rapid and delayed antidepressant-like behavioral effects, and these effects are likely medi-ated through distinct neurogenesis-dependent andindependent mechanisms.
Co-expression of LepRb and GR in adult hippocampal neural stem/progenitor cells
Stress-induced activation of GR is believed to mediate the suppressive effects of stress on neurogenesis. 89 Both GR and LepRb have been reported to be expressed in the dentate gyrus. 90, 91 To determine whether these two receptors coexist in hippocampal neural progenitor cells, we employed a triple-labeling detection method to demonstrate the colocalization of LepRb, GR and nestin, a marker of undifferentiated neural stem/progenitor cells, in the dentate gyrus. As shown in Figure 4a , LepRb and GR were distributed in the entire dentate gyrus, whereas nestin-positive cells were restricted to the subgranular zone. Colocalization of LepRb and GR was observed in nestinpositive cells in the subgranular zone of the dentate gyrus (Figure 4a ). In vitro studies demonstrated that GR was expressed in almost all nestin-positive cells ( Figure 4b ). The coexistence of LepRb, GR and nestin were confirmed in cultured hippocampal neural stem/progenitor cells (Figure 4b ). These observations provide the biological basis for a possible mechanism by which leptin antagonizes the effect of glucocorticoid stress hormones on hippocampal neurogenesis.
Effects of leptin and the GR agonist DEX on proliferation of adult hippocampal neural stem/ progenitor cells Cultured hippocampal neural stem/progenitor cells were treated with DEX and various doses of leptin for 48 h. ANOVA revealed a main effect of treatment (F (5,23) = 24.05, P < 0.0001). Post hoc tests indicated that DEX at a dose of 10 mM significantly reduced the number of BrdU-positive cells (P < 0.01; Figure 4c ), and this effect was attenuated by co-treatment with leptin at the doses of 1 and 3 nM (P = 0.01; Figure 4c ).
These results indicate that leptin produces a dose-related reversal of DEX-induced inhibition of adult hippocampal neural stem/progenitor cell proliferation.
Effects of leptin and DEX on the GSK-3b/b-catenin signaling pathway
To identify the molecular mechanisms by which leptin reverses the effect of DEX on hippocampal neural stem/progenitor cell proliferation, we examined the GSK-3b/b-catenin signaling pathway. GSK-3b phosphorylation at Ser9 and Tyr216 was detected 20 min after leptin (1 nM) and DEX (10 mM) treatment. ANOVA revealed main effects for leptin and DEX treatment on GSK-3b Ser9 phosphorylation (F (1,15) = 22.62, P < 0.001 for leptin; F (1,15) = 4.88, P < 0.05 for DEX) and only a significant main effect for DEX on Tyr216 phosphorylation (F (1, 15) = 0.93, P = 0.35 for leptin; F (1, 15) = 5.99, P < 0.05 for DEX). There was no significant interaction between leptin and DEX (F (1,15) = 2.26, P = 0.16 for Ser9 phosphorylation; F (1,15) = 1.04, P = 0.32 for Tyr216 phosphorylation). DEX decreased GSK-3b Ser9 phosphorylation and increased Tyr216 phosphorylation compared with vehicle treatment (P < 0.05), while leptin increased Ser9 phosphorylation (P < 0.001) and had no significant effect on Tyr216 phosphorylation (Figure 5a ). When leptin (1 nM) was co-administered with DEX, it reversed DEX-induced reduction of Ser9 phosphorylation (P < 0.001) and attenuated DEX-induced increase in Tyr216 phosphorylation (P = 0.1) ( Figure  5a ). Similar results were obtained 48 h after treatment with leptin and/or DEX (Supplementary Figure S2) . It is known that Ser9 phosphorylation inhibits GSK-3b activity and Tyr216 phosphorylation increases GSK-3b activity. [92] [93] [94] As active GSK-3b promotes b-catenin degradation, a reduction of GSK-3b activity would increase cytosolic levels of b-catenin and allow for its translocation from the cytoplasm to the nucleus. 95, 96 Therefore, the effects of leptin and DEX on the total cellular level of b-catenin and nuclear level of b-catenin were determined. The immunohistochemical staining showed that b-catenin immunoreactivity was primarily in the cytosol in hippocampal neural stem/progenitor cells treated with DEX, and co-treatment with leptin increased b-catenin immunoreactivity in the nucleus as well as in the cytosol (Figure 5b ). This finding was confirmed by measuring b-catenin levels in the total cell and nuclear fractions using Western blot assay. ANOVA revealed significant effects of DEX and leptin on total cellular level of b-catenin (F (1,11) = 6.77, P < 0.05 for DEX; F (1, 11) = 31.46, P < 0.001 for leptin). Post hoc analysis revealed that total b-catenin level was significantly decreased by DEX treatment alone (P < 0.05) and increased by leptin treatment alone (P < 0.01) compared with the vehicle-treated group (Figure 5c ). DEX-induced decrease in total b-catenin was significantly reversed by co-treatment with leptin (P < 0.001). Moreover, ANOVA revealed significant effects of DEX and leptin on nuclear b-catenin levels (F (1, 8) = 4.913, P < 0.05 for DEX; F (1, 8) = 50.147, P < 0.001 for leptin). Post hoc analysis showed that the level of b-catenin in the nucleus was reduced by DEX treatment (P < 0.05) and increased by leptin treatment (P < 0.001) when compared with the vehicle-treated group. The reduction in nuclear b-catenin induced by DEX was reversed by co-treatment with leptin ( Figure 5d ; P < 0.01). It is worth noting that there was a greater magnitude of increase in nuclear b-catenin (7-fold) than total b-catenin (1.5-fold) following leptin treatment, suggesting that leptin facilitates nuclear translocation of b-catenin. Taken together, these results suggest that the GSK-3b/b-catenin signaling pathway may underlie the effects of leptin and glucocorticoids on hippocampal neural stem/progenitor cell proliferation.
Discussion
In recent years, evidence has emerged that leptin plays a neurotrophic role in developing and adult brains. 69, [97] [98] [99] [100] [101] [102] Our previous studies have demonstrated that leptin has antidepressant-like activity 68, 103 and promotes basal adult hippocampal neurogenesis in non-stressed animals. 69 This study shows that chronic leptin treatment attenuates stress-induced suppression of hippocampal neurogenesis and depression-like behaviors. Hippocampal neurogenesis contributes to the long-lasting antidepressant-like behavioral effect of leptin. Leptin and stress hormones produce opposing effects on hippocampal neurogenesis, converging on the GSK-3b/b-catenin signaling pathway. The GR agonist DEX-induced inhibition of proliferation of cultured hippocampal neural stem/progenitor cells and changes in GSK-3b phosphorylation and b-catenin levels in the nucleus can be reversed by leptin treatment. These findings indicate that leptin is able to combat the deleterious consequences of chronic stress and excessive glucocorticoids on neurogenesis, possibly via acting on the GSK-3b/b-catenin signaling pathway.
Chronic unpredictable/variable/mild stress or chronic elevation of stress hormones have been demonstrated to induce suppression of hippocampal neurogenesis 38, 40, 41, 104 and behavioral symptoms mimicking those seen in major depression, 36, 40, [105] [106] [107] which can be reversed by administration of classical antidepressants. 26, 35, 36, 54, 67, 108 Consistent with previous findings, we showed that exposure to unpredictable stress for 21 days in rats decreased neurogenesis in the adult dentate gyrus and induced depressionlike behavioral deficits, including anhedonia and 'behavioral despair', as indicated by decreased sucrose preference and increased immobility in the forced swim test, respectively. Forced swim behavior has been inconsistent across studies. 40, 109 Differences in the types, intensity and durations of stress and behavioral testing conditions may account for the discrepancies. Chronic leptin treatment reversed CUS-suppressed cell proliferation in the adult hippocampus, an effect accompanied with improvement of anhedonia and 'behavioral despair'. However, CUSinduced changes in exploratory activity and freezing time, a rodent fear response, were not altered. In addition, while weight loss can be a symptom of depression, CUS-induced weight loss was slightly but significantly enhanced by leptin treatment in spite of the alleviation of depression-like behaviors. These findings suggest differential effects of leptin on chronic stress-induced cellular, behavioral and metabolic phenotypes in this CUS model. Although clear evidence for a causal link between adult neurogenesis and the development of depression is still lacking, recent studies support that behavioral actions of antidepressants might involve neurogenesis-dependent mechanisms. Some but not all behavioral effects of antidepressants can be blocked by selective ablation of neurogenesis, depending on the types of behavioral paradigms and the methods used to ablate neurogenesis. 8, 47, 62, 81, 84, [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] The behavioral effects of antidepressants on anhedonia and forced swimming have been reported to require neurogenesis. 36, 81, 121 These findings raise the possibility that leptin-induced increase in hippocampal neurogenesis might contribute to its antidepressant-like behavioral effects. To address this, we used a leptin treatment regimen that promotes hippocampal neurogenesis, followed by a time lag to permit new neurons to integrate into the hippocampal neuronal network and become fully functional. 122 We found that leptin treatment elicited significant effects on 'behavioral despair' in the forced swim test at 14 days after the cessation of leptin administration. This delayed behavioral effect of leptin was abolished by ablation of neurogenesis with X-irradiation suggesting that neurogenesis contributes to the delayed long-lasting antidepressant-like behavioral effect of leptin. Our previous studies have shown that leptin produces rapid effects on 'anhedonia' and 'behavioral despair', 68 presumably through neurogenesis-independent mechanisms. Leptin action on mature neurons in the hippocampus and other brain regions may mediate its acute and short-term behavioral effects.
Multiple lines of evidence support that inhibitory effects of stress on hippocampal cell proliferation are mediated by stress-induced glucocorticoid release. 12, 13, 31, 47, 50, [58] [59] [60] [61] [62] [63] [64] 123 This is likely to be due, at least in part, to a direct effect of glucocorticoids on hippocampal neural stem/progenitor cells. 73, 74 However, the molecular mechanisms underlying stress-and glucocorticoid-induced decrease in neurogenesis remains poorly understood. As reported previously, 124, 125 we demonstrated that activation of GR by the selective agonist DEX decreased the proliferation of cultured hippocampal neural stem/ progenitor cells. The colocalization of LepRb with GR in hippocampal neural stem/progenitor cells provided a biological basis for interaction between LepRb and GR signaling on cell proliferation. Reversal of DEX-induced decrease in the proliferation of hippocampal neural stem/progenitor cells by leptin in vitro is in agreement with the in vivo results in CUS rats. It should be pointed out, however, that the extrapolation of in vitro results to in vivo conditions is not straightforward. In vitro and in vivo studies differ in the experimental situations and treatment protocols. In cultures, the experimental conditions are well-controlled, and stem cells are isolated from differentiated neurons or glia. Thus, the pro-proliferative effects of leptin would reflect a direct mechanism. On the other hand, in vivo conditions could be modulated with time and by positive and negative regulatory factors derived from hippocampus and extra-hippocampal cells. It has been reported that differentiated neurons inhibit proliferation of neural progenitor cells. 126 This might partially explain why a longer time is required for leptin treatment in vivo than in vitro to produce a significant effect on neurogenesis. The combination of using an in vivo model to identify the neurogenic phenomenon with a well-controlled in vitro system to dissect the underlying molecular mechanisms would allow us to better understand the regulation of neurogenesis by leptin.
b-Catenin signaling plays an essential role in adult neurogenesis. [127] [128] [129] [130] [131] [132] b-Catenin is a primary substrate of GSK-3b, which phosphorylates N-terminal residues of b-catenin initiating rapid ubiquitin-mediated degradation by proteosomes. 95 GSK-3b activity is, in turn, regulated by phosphorylation on Ser9 and Tyr216. [92] [93] [94] While Ser9 phosphorylation inhibits GSK-3b activity, Tyr216 phosphorylation increases its activity. We found that DEX increased Tyr216 phosphorylation and decreased Ser9 phosphorylation in hippocampal neural stem/progenitor cells. The former change is consistent with a recent study by Boku et al. 124 However, they found that Ser9 phosphorylation was not affected by DEX treatment. This discrepancy could be due to different doses of DEX (10 mM in this study versus 5 mM in the study by Boku et al. 124 ) and detection times after DEX treatment (20 min in our study versus 72 h in the study by Boku et al. 124 ). One explanation may be that DEX-induced decrease in GSK-3b-Ser9 phosphorylation in this study is a transient phenomenon. However, this possibility is unlikely as our further study detected a significant reduction 48 h after DEX treatment. Changes in both Ser9 and Tyr216 phosphorylation induced by DEX were reversed by co-treatment with leptin. This would lead to additive decrease in GSK-3b activity and subsequent b-catenin accumulation in the cytosol and nuclear translocation, promoting cell proliferation by activating the lymphoid enhancer factor/T-cell factor family of transcription factors. 96 In consistence with this notion, leptin was shown to increase the total level and nuclear translocation of b-catenin, and reverse the inhibitory effects of DEX. These findings suggest that leptin and DEX converge on GSK-3b/bcatenin signaling in the regulation of hippocampal neural stem/progenitor cell proliferation.
Possible signal-transduction mechanisms underlying leptin regulation of GSK-3b/b-catenin activity may involve activation of the phosphatidylinositol-3kinase (PI3K)/AKT and the signal transducer and activator of transcription pathway 3 (STAT3) signaling pathways 69 (Figure 6 ). Both AKT and STAT3 signaling pathways are stimulated once leptin binds to LepRb. [133] [134] [135] [136] [137] It is well known that Akt phosphorylates GSK-3b on Ser9 and thereby inhibits GSK-3b activity. 92, 138 STAT3 has also been implicated in negative regulation of GSK-3b. Loss of STAT3 in peripheral tissue results in a net increase in active form of GSK-3b. 139 Inhibition of GSK-3b by leptinstimulated Akt and STAT3 signaling pathways would lead to increased b-catenin signaling and thus contribute to increased neurogenesis. Interestingly, b-catenin has been reported to induce de novo synthesis of brain-derived neurotrophic factor (BDNF), 140 which is an important regulator of adult hippocampal neurogenesis and behavioral effects of antidepressants. 21, [141] [142] [143] [144] [145] [146] [147] [148] Specifically, knockdown or knockout of BDNF in the dentate gyrus reduces neurogenesis, induces depression-like behavioral deficits and blocks behavioral response to antidepressants. 149, 150 Direct ablation of the BDNF receptor, TrkB, in hippocampal neural progenitor cells, leads Figure 6 Proposed mechanisms of leptin and glucocorticoid stress hormones in the glycogen synthase kinase-3b (GSK-3b)/ b-catenin signaling pathway. Leptin binds to the functional form of the leptin receptor, LepRb, and results in the phosphorylation and activation of phosphatidylinositol-3-kinase (PI3K)/AKT signaling pathway. This in turn phosphorylates GSK-3b on Ser9, resulting in decreased GSK-3b activity. In parallel, activated LepRb recruits JAK2 and initiates phosphorylation of signal transducer and activator of transcription pathway 3 (STAT3). Phosphorylated STAT3 acts on GSK-3b to reduce its activity. Glucocorticoids binding to glucocorticoid receptor (GR) induce phosphorylation of GSK-3b on Tyr216 and decreases phosphorylation on Ser9, consequently increasing GSK-3b activity. Increased GSK-3b activity reduces the stability of b-catenin and leads to b-catenin degradation through ubiquitination. Decreased GSK-3b activity increases the stability of b-catenin and results in the accumulation of b-catenin and its translocation into the nucleus, allowing interaction with members of the lymphoid enhancer factor/T-cell factor (LEF/TCF) family of transcription factors and, as a consequence, promoting the expression of cell proliferation genes.
to decreased basal proliferation and insensitivity to antidepressants. 143 Whether leptin interacts with BDNF in mediating neurogenesis under basal and stress conditions awaits future investigation.
In summary, our results suggest that leptin can reverse impaired hippocampal neurogenesis under chronic stress or excessive glucocorticoid conditions, and improve depression-like behaviors. These findings strengthen the new concept of adipostatic control of adult hippocampal neurogenesis and emotional behavior. Leptin is well known for its role in the regulation of food intake and body weight; deficiency of or resistance to leptin leads to obesity in rodents and humans. [152] [153] [154] [155] [156] [157] Given the findings that high fat diet induces leptin resistance and obesity, 158 impairs hippocampal neurogenesis and results in depressive behaviors, 151, 159, 160 further research will address whether leptin signaling is an important link between obesity, stress-related disorders and neurogenic/neuroplastic abnormalities.
